Cipla reported INR13.12B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Cipla INR 13.12B 792M Jun/2025
Dr.Reddys Laboratories INR 25.65B 10.39B Jun/2025
Life Technologies USD 4.93M 1.34M Jun/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 14.71B 3.06B Mar/2025